Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
NCT03305341· Early phase 1· Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error